Efficacy and safety of selective internal radiotherapy versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a systematic review and meta-analysis

Expert Review of Gastroenterology & Hepatology
Jingwen ZouJian Zhang

Abstract

Sorafenib (SOR) is recommended for locally advanced and metastatic hepatocellular carcinoma (HCC), but the tolerability of SOR is unsatisfactory. Selective internal radiotherapy (SIRT) has shown efficacy in intermediate-locally advanced HCC patients. This meta-analysis aimed to compare the efficacy and safety of SIRT and SOR in the treatment of intermediate-locally advanced HCC. We systematically searched the PubMed, Embase, Cochrane Library and Web of Science databases for eligible studies. The endpoints evaluated included the overall survival (OS), disease control rate (DCR), objective response rate (ORR) and grade≥3 adverse events (AEs). Six studies were included in this analysis. The OS was similar between the two groups (HR 1.06, 95%CI 0.93-1.20; P = 0.40). There was no difference in the DCR between the two groups (RR 1.13, 95%CI 0.87-1.46; P = 0.35). However, the ORR in the SIRT group was significantly higher than that in the SOR group (RR 4.10, 95%CI 1.92-8.76; P = 0.0003). The incidence rate of grade≥3 AEs was higher in the SOR group. In patients with intermediate-locally advanced HCC, SIRT and SOR result in similar survival rates. The improved toxicity profile of SIRT may help when choosing between the two treatments.

References

Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M LlovetJ Bruix
Oct 7, 2000·Journal of Gastroenterology and Hepatology·A PawarodeN Voravud
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chung-Mau LoJohn Wong
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pierce K h ChowUNKNOWN Asian-Pacific Hepatocellular Carcinoma Trials Group
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Dec 14, 2004·International Journal of Radiation Oncology, Biology, Physics·Andrew S KennedyCinthia Drachenberg
Aug 15, 2006·International Journal of Radiation Oncology, Biology, Physics·Bruno SangroJesus Prieto
Dec 16, 2006·World Journal of Gastroenterology : WJG·Masami Minagawa, Masatoshi Makuuchi
Jan 19, 2007·World Journal of Gastroenterology : WJG·Kiminori UkaKazuaki Chayama
May 24, 2007·British Journal of Cancer·T Kamba, D M McDonald
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ultan McDermottJeffrey Settleman
Feb 29, 2008·Journal of Hepatology·Josep M Llovet, Jordi Bruix
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Dec 9, 2010·The Oncologist·Alan P VenookLaura Ladrón de Guevara
May 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bruno SangroUNKNOWN European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY)
Aug 6, 2011·Journal of Hepatology·Bruno SangroJose I Bilbao
Sep 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Massimo IavaroneUNKNOWN SOFIA (SOraFenib Italian Assessment) study group
Nov 24, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Seanthan SenthilnathanRiad Salem
Jan 14, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ann-Lii ChengYoon-Koo Kang
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C VerslypeUNKNOWN ESMO Guidelines Working Group
Feb 23, 2013·Journal of Vascular and Interventional Radiology : JVIR·Rita GolfieriUNKNOWN Bologna Liver Oncology Group (BLOG)
Apr 23, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Annagiulia GramenziUNKNOWN BLOG (Bologna Liver Oncology Group)
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Feb 6, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N Ofek ShlomaiS Patole
Oct 13, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Julien EdelineEtienne Garin
Feb 26, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Manuel A de la TorreBruno Sangro
Jan 9, 2018·Lancet·Alejandro FornerJordi Bruix

❮ Previous
Next ❯

Citations

Aug 5, 2020·BMC Gastroenterology·Alessandra MangiaEugenio Caturelli
Jul 2, 2021·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Antonio FacciorussoRodolfo Sacco

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.